Health
Pancreatic Cancer Treatment Breakthrough
Incyte's new pancreatic cancer drug, when combined with chemotherapy, has shown promising results in inducing lasting tumor responses. This could be a significant step forward for patients suffering from the disease.
Coverage timeline — 2 articles
STAT News
"I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.
2026-04-17 17:37 UTC
STAT News
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer
2026-10-26 13:57 UTC